KY HB547 | 2012 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on March 1 2012 - 25% progression, died in committee
Action: 2012-03-05 - to Health & Welfare (H)
Pending: House Health and Welfare Committee
Text: Latest bill text (Draft #1) [MS Word]
Status: Introduced on March 1 2012 - 25% progression, died in committee
Action: 2012-03-05 - to Health & Welfare (H)
Pending: House Health and Welfare Committee
Text: Latest bill text (Draft #1) [MS Word]
Summary
Create a new section of KRS Chapter 205 to define the terms "cabinet," "maximum allowable cost," and "multiple source drug"; permit a Medicaid managed care organization contracting with the cabinet to establish a maximum allowable cost for a drug if there are at least two or more bioequivalent or therapeutically equivalent multiple source noninnovator drugs available; establish criteria for determining the maximum allowable cost; require a Medicaid managed care organization to establish a process for a provider to appeal the maximum allowable cost.
Title
AN ACT relating to Medicaid prescription drugs.
Sponsors
| Rep. John Stacy [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2012-03-05 | to Health & Welfare (H) | |
| 2012-03-01 | introduced in House |
Kentucky State Sources
| Type | Source |
|---|---|
| Summary | http://www.lrc.ky.gov/record/12RS/HB547.htm |
| Text | http://www.lrc.ky.gov/record/12RS/HB547/bill.doc |
